ArticleOxidative medicine and cellular longevity2022

NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma.

Anni Immonen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.